These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 37122429)

  • 1. Validity and reliability of the Polish version of the Michigan Neuropathy Screening Instrument.
    Sutkowska E; Marciniak D; Koszewicz M; Dziadkowiak E; Budrewicz S; Biernat K; Kuciel N; Mazurek J; Hap K
    World J Diabetes; 2023 Apr; 14(4):435-446. PubMed ID: 37122429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Turkish version of the Michigan Neuropathy Screening Instrument in the assessment of diabetic peripheral neuropathy: a validity and reliability study.
    Kaymaz S; Alkan H; Karasu U; Çobankara V
    Diabetol Int; 2020 Jul; 11(3):283-292. PubMed ID: 32802710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation and Reliability of the Portuguese Version of the Michigan Neuropathy Screening Instrument.
    Barbosa M; Saavedra A; Severo M; Maier C; Carvalho D
    Pain Pract; 2017 Apr; 17(4):514-521. PubMed ID: 27538385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validity and reliability of the Turkish version of the Michigan Neuropathy Screening Instrument.
    Aktar Reyhanioğlu D; Adiyaman SC; Bektaş M; Bulut O; Özgen Saydam B; Bayraktar F; Kara B
    Turk J Med Sci; 2020 Jun; 50(4):789-797. PubMed ID: 32178509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Precision of Michigan Neuropathy Screening Instrument (MNSI) Tool for the Diagnosis of Diabetic Peripheral Neuropathy Among People with Type 2 Diabetes-A Study from South India.
    Viswanathan V; Ahmed Khan B; Nachimuthu S; Kumpatla S
    Int J Low Extrem Wounds; 2023 Mar; ():15347346231163209. PubMed ID: 36924005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Translation, validation, and diagnostic accuracy of the Arabic version of the Michigan neuropathy screening instrument.
    Abuzinadah AR; Alkully HS; Alanazy MH; Alrawaili MS; Milyani HA; AlAmri B; AlShareef AA; Bamaga AK
    Medicine (Baltimore); 2021 Nov; 100(44):e27627. PubMed ID: 34871227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of Michigan neuropathy screening instrument for diabetic peripheral neuropathy.
    Moghtaderi A; Bakhshipour A; Rashidi H
    Clin Neurol Neurosurg; 2006 Jul; 108(5):477-81. PubMed ID: 16150538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross-cultural adaptation and measurement properties of the Brazilian Version of the Michigan Neuropathy Screening Instrument.
    Sartor CD; Oliveira MD; Campos V; Ferreira JSSP; Sacco ICN
    Braz J Phys Ther; 2018; 22(3):222-230. PubMed ID: 29175181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of Michigan neuropathy screening instrument, United Kingdom screening test and electrodiagnosis for early detection of diabetic peripheral neuropathy.
    Fateh HR; Madani SP; Heshmat R; Larijani B
    J Diabetes Metab Disord; 2015; 15():8. PubMed ID: 27019831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reliability and Validity of Mini-Balance Evaluation System Test in Type 2 Diabetic Patients with Peripheral Neuropathy.
    Phyu SN; Peungsuwan P; Puntumetakul R; Chatchawan U
    Int J Environ Res Public Health; 2022 Jun; 19(11):. PubMed ID: 35682526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of the Michigan Neuropathy Screening Instrument as a measure of distal symmetrical peripheral neuropathy in Type 1 diabetes: results from the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications.
    Herman WH; Pop-Busui R; Braffett BH; Martin CL; Cleary PA; Albers JW; Feldman EL;
    Diabet Med; 2012 Jul; 29(7):937-44. PubMed ID: 22417277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SUDOSCAN in Combination with the Michigan Neuropathy Screening Instrument Is an Effective Tool for Screening Diabetic Peripheral Neuropathy.
    Oh TJ; Song Y; Jang HC; Choi SH
    Diabetes Metab J; 2022 Mar; 46(2):319-326. PubMed ID: 34525791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Translation and Psychometric Properties of the Arabic Version of Michigan Neuropathy Screening Instrument in Type 2 Diabetes.
    Mohammad MT; Muhaidat J; Momani MS; Al-Khlaifat L; Okasheh R; Qutishat D; Al-Yahya E
    J Diabetes Res; 2019; 2019():2673105. PubMed ID: 31049355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Standard Clinical Screening Tests, Sural Radial Amplitude Ratio and F Wave Latency Compared to Conventional Nerve Conduction Studies in the Assessment of Sensorimotor Polyneuropathy in Patients with Type 2 Diabetes Mellitus.
    Ramanathan S; Thomas R; Chanu AR; Naik D; Jebasingh F; Sivadasan A; Thomas N
    Indian J Endocrinol Metab; 2021; 25(6):509-515. PubMed ID: 35355904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A simplified diagnostic test for ambulatory screening of peripheral diabetic neuropathy.
    Lunetta M; Le Moli R; Grasso G; Sangiorgio L
    Diabetes Res Clin Pract; 1998 Mar; 39(3):165-72. PubMed ID: 9649948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Machine Learning-Based Severity Prediction Tool for the Michigan Neuropathy Screening Instrument.
    Haque F; Reaz MBI; Chowdhury MEH; Shapiai MIB; Malik RA; Alhatou M; Kobashi S; Ara I; Ali SHM; Bakar AAA; Bhuiyan MAS
    Diagnostics (Basel); 2023 Jan; 13(2):. PubMed ID: 36673074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validity and reliability of an adapted arabic version of the long international physical activity questionnaire.
    Helou K; El Helou N; Mahfouz M; Mahfouz Y; Salameh P; Harmouche-Karaki M
    BMC Public Health; 2017 Jul; 18(1):49. PubMed ID: 28738790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prevalence of diabetic peripheral neuropathy among diabetic Palestinian refugees in the Nuzha area, Jordan: a cross-sectional study.
    Atallah SM; Al-Jaghbir MT; Zayed AA
    Lancet; 2021 Jul; 398 Suppl 1():S15. PubMed ID: 34227946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A comparison of clinical effectiveness of different neuropathy scoring systems in screening asymptomatic diabetic peripheral neuropathy].
    Hu H; Li H; Zheng FP; Cheng Y; Miao J; Zhang W
    Zhonghua Nei Ke Za Zhi; 2012 Jan; 51(1):13-7. PubMed ID: 22490752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A nomogram-based diabetic sensorimotor polyneuropathy severity prediction using Michigan neuropathy screening instrumentations.
    Haque F; Ibne Reaz MB; Chowdhury MEH; Md Ali SH; Ashrif A Bakar A; Rahman T; Kobashi S; Dhawale CA; Sobhan Bhuiyan MA
    Comput Biol Med; 2021 Dec; 139():104954. PubMed ID: 34715551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.